• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于深度学习乳腺X线摄影的乳腺癌风险模型、其系列变化及乳腺癌死亡率。

Deep learning mammography-based breast cancer risk model, its serial change, and breast cancer mortality.

作者信息

Shin Sujeong, Chang Yoosoo, Ryu Seungho

机构信息

Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

Breast Cancer. 2025 Sep 3. doi: 10.1007/s12282-025-01772-w.

DOI:10.1007/s12282-025-01772-w
PMID:40900381
Abstract

BACKGROUND

Although numerous breast cancer risk prediction models have been developed to categorize individuals by risk, a substantial gap persists in evaluating how well these models predict actual mortality outcomes. This study aimed to investigate the association between Mirai, a deep learning model for risk prediction based on mammography, and breast cancer-specific mortality in a large cohort of Korean women.

METHODS

This retrospective cohort study examined 124,653 cancer-free women aged ≥ 34 years who underwent mammography screening between 2009-2020. Participants were stratified into tertiles by Mirai risk scores and categorized into four groups based on risk changes over time. Cox proportional hazards regression models were used to evaluate the associations of both baseline Mirai scores and temporal risk changes with breast cancer-specific mortality.

RESULTS

Over 1,075,177 person-years of follow-up, 31 breast cancer-related deaths occurred. The highest Mirai risk tertile showed significantly higher breast cancer-specific mortality than the lowest tertile (hazard ratio [HR], 5.34; 95% confidence interval [CI] 1.17-24.39; p for trend = 0.020). Temporal Mirai score changes were associated with mortality risk: those remaining in the high-risk (HR, 5.92; 95% CI 1.43-24.49) or moving from low to high risk (HR, 5.57; 95% CI 1.31-23.63) had higher mortality rates than those staying in low-risk.

CONCLUSIONS

The Mirai model, developed to predict breast cancer incidence, was significantly associated with breast cancer-specific mortality. Changes in Mirai risk scores over time were also linked to breast cancer-specific mortality, supporting AI-based risk models in guiding risk-stratified screening and prevention of breast cancer-related deaths.

摘要

背景

尽管已经开发了许多乳腺癌风险预测模型来按风险对个体进行分类,但在评估这些模型对实际死亡率结果的预测效果方面仍存在很大差距。本研究旨在调查基于乳房X线摄影的深度学习风险预测模型Mirai与大量韩国女性队列中乳腺癌特异性死亡率之间的关联。

方法

这项回顾性队列研究检查了124,653名年龄≥34岁的无癌女性,她们在2009年至2020年期间接受了乳房X线摄影筛查。参与者按Mirai风险评分分为三分位数,并根据随时间的风险变化分为四组。使用Cox比例风险回归模型来评估基线Mirai评分和时间风险变化与乳腺癌特异性死亡率之间的关联。

结果

在超过1,075,177人年的随访中,发生了31例与乳腺癌相关的死亡。Mirai风险最高的三分位数显示出比最低三分位数显著更高的乳腺癌特异性死亡率(风险比[HR],5.34;95%置信区间[CI]1.17-24.39;趋势p值=0.020)。Mirai评分随时间的变化与死亡风险相关:那些保持高风险(HR,5.92;95%CI 1.43-24.49)或从低风险转变为高风险(HR,5.57;95%CI 1.31-23.63)的人比那些保持低风险的人有更高的死亡率。

结论

为预测乳腺癌发病率而开发的Mirai模型与乳腺癌特异性死亡率显著相关。Mirai风险评分随时间的变化也与乳腺癌特异性死亡率相关,支持基于人工智能的风险模型指导风险分层筛查和预防乳腺癌相关死亡。

相似文献

1
Deep learning mammography-based breast cancer risk model, its serial change, and breast cancer mortality.基于深度学习乳腺X线摄影的乳腺癌风险模型、其系列变化及乳腺癌死亡率。
Breast Cancer. 2025 Sep 3. doi: 10.1007/s12282-025-01772-w.
2
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.乳腺 X 线摄影联合乳腺超声与乳腺 X 线摄影用于一般风险女性乳腺癌筛查。
Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
6
Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline.乳腺癌筛查:为为加拿大预防性医疗保健指南提供信息而进行的系统评价更新
Syst Rev. 2024 Dec 19;13(1):304. doi: 10.1186/s13643-024-02700-3.
7
The Prognostic Potential of Insulin-like Growth Factor-Binding Protein 1 for Cardiovascular Complications in Peripheral Artery Disease.胰岛素样生长因子结合蛋白1对周围动脉疾病心血管并发症的预后评估价值
J Cardiovasc Dev Dis. 2025 Jul 1;12(7):253. doi: 10.3390/jcdd12070253.
8
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2022.韩国癌症统计数据:2022年的发病率、死亡率、生存率和患病率
Cancer Res Treat. 2025 Apr;57(2):312-330. doi: 10.4143/crt.2025.264. Epub 2025 Mar 11.
2
Outcomes of Stereotactic Body Radiation Therapy for Large Uveal Melanoma: A Retrospective Analysis of Asian Population.
Cancer Res Treat. 2024 Dec 31. doi: 10.4143/crt.2024.580.
3
Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health Initiative.乳腺癌风险评估工具(BCRAT)与女性健康倡议中的长期乳腺癌死亡率
Breast Cancer Res Treat. 2025 Jan;209(1):49-60. doi: 10.1007/s10549-024-07470-z. Epub 2024 Sep 10.
4
Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.乳腺癌筛查:美国预防服务工作组的证据报告和系统评价。
JAMA. 2024 Jun 11;331(22):1931-1946. doi: 10.1001/jama.2023.25844.
5
Use of an AI Score Combining Cancer Signs, Masking, and Risk to Select Patients for Supplemental Breast Cancer Screening.利用 AI 评分综合癌症征象、伪装和风险来选择需要补充乳腺癌筛查的患者。
Radiology. 2024 Apr;311(1):e232535. doi: 10.1148/radiol.232535.
6
Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates.基于癌症干预和监测建模网络估计的乳腺癌筛查策略的结果。
Radiology. 2024 Feb;310(2):e232658. doi: 10.1148/radiol.232658.
7
Benefits of Breast Cancer Screening and Treatment on Mortality.乳腺癌筛查与治疗对死亡率的益处。
JAMA. 2024 Jan 16;331(3):199-200. doi: 10.1001/jama.2023.26730.
8
Assessing Breast Cancer Risk by Combining AI for Lesion Detection and Mammographic Texture.利用人工智能进行病灶检测和乳腺纹理分析来评估乳腺癌风险。
Radiology. 2023 Aug;308(2):e230227. doi: 10.1148/radiol.230227.
9
Evaluation of an AI Model to Assess Future Breast Cancer Risk.评估人工智能模型预测未来乳腺癌风险的研究
Radiology. 2023 Jun;307(5):e222679. doi: 10.1148/radiol.222679.
10
Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study.对比钼靶 X 线摄影人工智能算法与临床风险模型预测 5 年乳腺癌风险:一项观察性研究。
Radiology. 2023 Jun;307(5):e222733. doi: 10.1148/radiol.222733.